<?xml version="1.0" encoding="UTF-8"?>
<list>
  <sentences>
    <s path="[OANC]/data/written_2/technical/biomed/cc1529.anc" start="14180" end="14185" sStart="14156" offset="24" sid="null" wn="1" wnkey="use%2:34:01::" annotator="veweser" text="The all-survivors group using the last observation carried forward analysis totaled 897 patients, whereas the in-hospital group totaled 118." />
    <s path="[OANC]/data/written_2/technical/biomed/cc1529.anc" start="14180" end="14185" sStart="null" offset="24" sid="null" wn="1" wnkey="use%2:34:01::" annotator="jeneale" text="The all-survivors group using the last observation carried forward analysis totaled 897 patients, whereas the in-hospital group totaled 118." />
    <s path="[OANC]/data/written_2/technical/biomed/cc1529.anc" start="14180" end="14185" sStart="null" offset="24" sid="null" wn="1" wnkey="use%2:34:01::" annotator="cgozo" text="The all-survivors group using the last observation carried forward analysis totaled 897 patients, whereas the in-hospital group totaled 118." />
    <s path="[OANC]/data/written_2/technical/biomed/cc1529.anc" start="11609" end="11613" sStart="null" offset="150" sid="r7.1.use.v.0976" wn="1" wnkey="use%2:34:01::" annotator="cgozo" text="In the SAPS II system, a score-to-risk transformation developed by Le Gall et al . [ 16] for sepsis patients was used." />
    <s path="[OANC]/data/written_2/technical/biomed/cc1529.anc" start="14180" end="14185" sStart="null" offset="24" sid="null" wn="1" wnkey="use%2:34:01::" annotator="brubin" text="The all-survivors group using the last observation carried forward analysis totaled 897 patients, whereas the in-hospital group totaled 118." />
    <s path="[OANC]/data/written_2/technical/biomed/cc1529.anc" start="9448" end="9452" sStart="null" offset="181" sid="r7.1.use.v.0547" wn="1" wnkey="use%2:34:01::" annotator="brubin" text="In cases in which there was no patient response at 90 days because they had been discharged, the data from the last assessment but before 90 days were used." />
    <s path="[OANC]/data/written_2/technical/biomed/cc1529.anc" start="4320" end="4326" sStart="null" offset="42" sid="null" wn="6" wnkey="severe%5:00:01:bad:00" annotator="vebatchelder" text="Unfortunately, patients hospitalized with severe sepsis may be unable to complete a QoL measure or it may be too burdensome." />
    <s path="[OANC]/data/written_2/technical/biomed/cc1529.anc" start="20501" end="20507" sStart="null" offset="91" sid="r11.severe.j.0472" wn="1" wnkey="severe%5:00:00:intense:00" annotator="vebatchelder" text="The results of the study indicate that, over a 90-day period, survivors of severe sepsis receiving AT III experienced substantial and statistically significant improvements as compared with placebo in several attributes of QoL." />
    <s path="[OANC]/data/written_2/technical/biomed/cc1529.anc" start="4112" end="4118" sStart="null" offset="87" sid="r11.severe.j.0469" wn="1" wnkey="severe%5:00:00:intense:00" annotator="vebatchelder" text="QoL gives information on what medical care has achieved for the patient, but severe sepsis is a difficult area in which to obtain such information." />
    <s path="[OANC]/data/written_2/technical/biomed/cc1529.anc" start="4320" end="4326" sStart="null" offset="42" sid="null" wn="1" wnkey="severe%5:00:00:intense:00" annotator="anfahmy" text="Unfortunately, patients hospitalized with severe sepsis may be unable to complete a QoL measure or it may be too burdensome." />
    <s path="[OANC]/data/written_2/technical/biomed/cc1529.anc" start="23193" end="23199" sStart="null" offset="55" sid="r11.severe.j.0473" wn="5" wnkey="severe%5:00:00:critical:03" annotator="anfahmy" text="Future studies of critically ill patients with severe sepsis or other conditions should include long-term follow up of patients throughout hospitalization and after hospital discharge." />
    <s path="[OANC]/data/written_2/technical/biomed/cc1529.anc" start="4320" end="4326" sStart="null" offset="42" sid="r11.severe.j.0470" wn="5" wnkey="severe%5:00:00:critical:03" annotator="anfahmy" text="Unfortunately, patients hospitalized with severe sepsis may be unable to complete a QoL measure or it may be too burdensome." />
    <s path="[OANC]/data/written_2/technical/biomed/cc1529.anc" start="2511" end="2517" sStart="null" offset="138" sid="r11.severe.j.0467" wn="5" wnkey="severe%5:00:00:critical:03" annotator="anfahmy" text="The purpose of this investigation was to establish whether these trends also held for the subjective effects of AT III in severe sepsis." />
    <s path="[OANC]/data/written_2/technical/biomed/cc1529.anc" start="71" end="77" sStart="null" offset="26" sid="r11.severe.j.0087" wn="5" wnkey="severe%5:00:00:critical:03" annotator="anfahmy" text="In treating patients with severe sepsis, physicians are mainly concerned with biologic, physiologic, and clinical outcomes." />
    <s path="[OANC]/data/written_2/technical/biomed/cc1529.anc" start="4320" end="4326" sStart="null" offset="42" sid="null" wn="1" wnkey="severe%5:00:00:intense:00" annotator="adelpriore" text="Unfortunately, patients hospitalized with severe sepsis may be unable to complete a QoL measure or it may be too burdensome." />
  </sentences>
</list>